ABBV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
AbbVie Inc's quarterly accounts payable declined from Mar. 2014 ($6,196 Mil) to Jun. 2014 ($6,046 Mil) but then increased from Jun. 2014 ($6,046 Mil) to Sep. 2014 ($6,312 Mil).
AbbVie Inc's annual accounts payable declined from Dec. 2011 ($5,897 Mil) to Dec. 2012 ($5,734 Mil) and declined from Dec. 2012 ($5,734 Mil) to Dec. 2013 ($4,917 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
AbbVie Inc Annual Data
AbbVie Inc Quarterly Data